Laboratory Tests for Joint Pain Evaluation

Initial Laboratory Panel

The American College of Rheumatology recommends obtaining inflammatory markers (ESR and CRP), autoimmune panel (RF, anti-CCP, ANA), and complete blood count as initial laboratory workup for undifferentiated joint pain, with additional testing guided by clinical presentation and severity 1, 2, 3
Inflammatory markers (ESR and CRP) should be obtained in all patients with joint pain, as these provide complementary information about disease activity and help differentiate inflammatory from non-inflammatory conditions 1, 3, 4
Complete blood count (CBC) with differential should be performed to evaluate for systemic infection, anemia of chronic disease, and leukocytosis 2, 4
Autoimmune panel including rheumatoid factor (RF) and anti-CCP antibodies is strongly predictive of rheumatoid arthritis diagnosis and prognosis, and antinuclear antibodies (ANA) should be included if connective tissue disease is suspected 1, 3

For patients with mild pain and inflammation, consider autoimmune blood panel including ANA, RF, anti-CCP, ESR, and CRP if symptoms persist, and add HLA-B27 testing if symptoms suggest reactive arthritis or affect the spine 1, 2
For patients with moderate to severe pain, perform all initial laboratory tests, and test for viral hepatitis B and C, and latent or active tuberculosis before initiating DMARD therapy 1, 2

Baseline testing should include CBC with differential, liver function tests (ALT, AST), and renal function tests (BUN, creatinine, urinalysis) for methotrexate, sulfasalazine, and NSAIDs, and lipid profiles for tocilizumab and tofacitinib 5

Monitoring schedule for NSAIDs should include CBC, LFTs, and renal function every 6-12 months, and for methotrexate, CBC, LFTs, and renal function within first 1-2 months, then every 3-4 months 5
Inflammatory markers (ESR and CRP) should be monitored every 4-6 weeks after treatment initiation 1, 2

Joint aspiration with fluid analysis is indicated when infection is suspected, guided by imaging, as recommended by the American College of Radiology 6